AtriCure (NASDAQ:ATRC) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $40.17, with a high estimate of $49.00 and a low estimate of $32.00. A decline of 13.05% from the prior average price target is evident in the current average.

Investigating Analyst Ratings: An Elaborate Study

The standing of AtriCure among financial experts becomes clear with...